Patents expiring in 2028

US 7465716

Targeted drug delivery with a hyaluronan ligand

The Regents of the University of California · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465715

Method for treatment of multiple sclerosis

CAN-FITE BIOPHARMA LTD. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465466

Compositions and methods for prostate and kidney health and disorders, an herbal preparation

Integrated Chinese Medicine Holdings Ltd. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465449

Anti-αvβ6 antibodies

The Regents of the University of California · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465738

Compounds useful as promoters of SMN2

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465815

Cannabinoid receptor modulator

Takeda Pharmaceutical Company Limited · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465831

Levalbuterol hydrochloride Polymorph A

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7465825

Phenyl substituted carboxylic acids

The Institute for Pharmaceutical Discovery, LLC · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468444

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468426

Oncoprotein protein kinase antibody kit

The Regents of the University of California · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468432

Cobalamin conjugates useful as antitumor agents

Regents of the University of Minnesota · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468394

Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation

Amphastar Pharmaceuticals, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468420

Process for purifying glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468419

Cyclosporin derivatives for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468352

Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468379

Inhibition of osteolytic lesions by SRC kinase inhibitors

The Board of Regents of the University of Texas System · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7468435

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470660

Treatment for dark adaptation

The Regents of the University of California · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470775

Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470790

Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

Northwestern University · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470700

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470776

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470420

Optical determination of glucose utilizing boronic acid adducts

The Regents of the University of California · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470430

Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470431

Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

The Regents of the University of Colorado · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470659

Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)

The Regents of the University of California · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7470506

Fitness assay and associated methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)